Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000679624 | SCV000653232 | likely benign | not provided | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000679624 | SCV000806765 | likely benign | not provided | 2017-12-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000679004 | SCV002621294 | likely benign | Hereditary cancer-predisposing syndrome | 2019-10-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Mayo Clinic Laboratories, |
RCV000679624 | SCV004226397 | uncertain significance | not provided | 2022-04-04 | criteria provided, single submitter | clinical testing | |
True Health Diagnostics | RCV000679004 | SCV000805297 | likely benign | Hereditary cancer-predisposing syndrome | 2018-06-05 | no assertion criteria provided | clinical testing |